We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Herald Investment Trust Plc | LSE:HRI | London | Ordinary Share | GB0004228648 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2,050.00 | 2,045.00 | 2,060.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Mgmt Invt Offices, Open-end | 63.35M | 48.12M | 0.8713 | 23.47 | 1.13B |
TIDMHRI
RNS Number : 4552P
Herald Investment Trust PLC
20 June 2022
Herald Investment Trust plc (the "Company")
LEI: 213800U7G1ROCTJYRR70
Appointment of Andrew Joy as a non-executive director
Following a comprehensive selection process, conducted using a third-party search firm, Herald Investment Trust plc is pleased to announce the appointment of Andrew Joy as an independent non-executive director and chairman-designate of the Company with effect from 1 October 2022. Andrew is expected to succeed Tom Black as the Company's Chairman at the conclusion of the next AGM in April 2023 when Tom will stand down from the Board having completed nearly ten years of service. During the interim period, Tom will work closely with Andrew to ensure an orderly transition.
Andrew is currently chairman of The Biotech Growth Trust plc, a position he has held since July 2016 having joined the board in 2012 as a non-executive director. The Biotech Growth Trust has announced that Andrew is expected to retire from that role in July 2022. He is also a senior advisor of Stonehage Fleming, a leading international multi-family office, chairman of the investment committee of FPE Capital and is a trustee of several charities. For one of these charities, he chairs the investment committee of a GBP300 million endowment.
Andrew is highly regarded for his extensive knowledge of the financial sector and of the high-growth part of the smaller company sector. He was one of the founding partners of Cinven, a leading private equity firm investing in Europe and U.S. and has been chairman or director of numerous growth companies over the past 30 years. He is former chairman of the British Venture Capital and Private Equity Association and a director of the European Venture Capital Association.
There is no other information required to be disclosed under section 9.6.13 of the Listing Rules in respect of Andrew Joy.
20 June 2022
Enquiries
Sanne Fund Services (UK) Limited
Shilla Pindoria 020 3327 9720
Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAPPUMPQUPPURU
(END) Dow Jones Newswires
June 20, 2022 05:00 ET (09:00 GMT)
1 Year Herald Investment Chart |
1 Month Herald Investment Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions